ID: ALA2071626

Max Phase: Preclinical

Molecular Formula: C13H12BrNO2

Molecular Weight: 294.15

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)C(=O)Oc1ccc2ccccc2c1Br

Standard InChI:  InChI=1S/C13H12BrNO2/c1-15(2)13(16)17-11-8-7-9-5-3-4-6-10(9)12(11)14/h3-8H,1-2H3

Standard InChI Key:  LFIQVKLNAVCFNU-UHFFFAOYSA-N

Associated Targets(Human)

Neutral cholesterol ester hydrolase 1 158 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.15Molecular Weight (Monoisotopic): 293.0051AlogP: 3.66#Rotatable Bonds: 1
Polar Surface Area: 29.54Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.45CX LogD: 3.45
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.80Np Likeness Score: -0.76

References

1. Shreder KR, Lin EC, Wu J, Cajica J, Amantea CM, Hu Y, Okerberg E, Brown HE, Pham LM, Chung de M, Fraser AS, McGee E, Rosenblum JS, Kozarich JW..  (2012)  Synthesis and structure-activity relationship of (1-halo-2-naphthyl) carbamate-based inhibitors of KIAA1363 (NCEH1/AADACL1).,  22  (17): [PMID:22877630] [10.1016/j.bmcl.2012.05.102]

Source